STALORAL 300 IR Sublingual Immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STALORAL 300 IR Sublingual Immunotherapy, covering 2011-10-12 to 2011-10-12. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites [Phase 3]